Insights

A 55-Year-Old Woman With Epilepsy

Epilepsy Prevalence and Therapy Resistance

Seizure Classification and Goals of Therapy

Antiepileptic Therapy Half-Life, Dosing & Black Box Warning

Antiepileptic Therapy Adverse Effects and Nonadherence

How Treatment Efficacy Is Determined

A Treatment Option for Uncontrolled Partial-Onset Seizures

Real-World Practice: Perampanel for Partial-Onset Seizures

Epilepsy Case Presentation and Diagnostic Process

The Classification of Epilepsy and Seizures

Anticonvulsants to Treat Epilepsy and Alternatives

How Epilepsy Treatment Efficacy Is Determined

Addressing Nonadherence to Therapy

Treating Patients Who Are Unresponsive to Therapy

Burden of Migraine

Acute Migraine Treatment Goals

Advances in the Treatment of Acute Migraine

Rimegepant Treatment for Acute Migraine

Gepants for Acute Migraine: Safety & Efficacy Data

Gepants for Acute Migraine: Patient Management

Real-World Experience With Gepants for Acute Migraine

Acute Migraine Treatment: What’s Next?

Treating Acute Migraine in the Community Setting

Treatment Goals for Acute Migraine

Acute Migraine Treatment Goals

Patient Selection for Acute Migraine Therapy

Rimegepant: Treatment for Acute Migraine

Ubrogepant: Treatment for Acute Migraine

Therapies in Development for Acute Migraine

Overview of OFF Episodes in Parkinson’s Disease

Apomorphine Subcutaneous Injection: Historical Perspective for Off-Episodes in Parkinson’s Disease

Apomorphine Subcutaneous Injection: Efficacy and Administration for Off-Episodes in Parkinson Disease

Apomorphine Subcutaneous Injection: Patient Selection for Off-Episodes in Parkinson Disease

Apomorphine Subcutaneous Injection: Circle of Care Program for Off-Episodes in Parkinson Disease

Recent Approval of Sublingual Apomorphine for Off-Episodes in Parkinson Disease

Continuous Subcutaneous Apomorphine Infusion in Development for OFF Episodes in Parkinson’s Disease

Levodopa Inhalation Powder for OFF Episodes in Parkinson’s Disease

Recently Approved Oral Therapies for OFF Episodes in Parkinson’s Disease

Device-Assisted and Surgical Options for Advanced Motor Fluctuations in Parkinson’s Disease

Treating OFF Episodes in Parkinson’s Disease During COVID-19

Overview of Spinal Muscular Atrophy

Spectrum of SMA Phenotypes at Presentation

Genetic Testing in SMA

Considerations When Diagnosing SMA

Assessing Motor Function in Later-Onset SMA

Multidisciplinary Management of SMA

Nusinersen Treatment for SMA

The ENDEAR and CHERISH Trials in SMA

Nusinersen in Adults With 5q SMA

Real-World Experience Treating SMA With Nusinersen

Risdiplam Under Study to Treat SMA

Drugs in Development and Next Steps

Treating SMA in the Community

Overview of Duchenne Muscular Dystrophy

Diagnosis of Duchenne Muscular Dystrophy

Becker Muscular Dystrophy vs Duchenne Muscular Dystrophy

Multidisciplinary Management of DMD

Role of Genetic Counseling and Psychosocial Support in DMD

Supportive Treatment Options for DMD

Use of Corticosteroids in DMD Management

Treatments in Development for DMD

Advice for Treatment of DMD

Advice for Treatment of DMD

Reviewing a Case of Parkinson Disease OFF Episodes

Off Episodes in a 63-Year-Old Woman With Parkinson

Differentiating Off Episodes in Parkinson Disease

Improving QoL in Patients with Parkinson Disease

Shifting the Paradigm to On-Demand Therapies in PD

Inhalation Powder for Off Episodes of Parkinson Disease

Different Types of OFF Episodes in Parkinson Disease

Educating Patients on Signs of Parkinson Disease OFF Episodes

Gastroparesis and Uptake of Oral Medication for Parkinson Disease

Altering Oral PD Regimens Versus Using On-Demand Therapy

PD OFF Episodes: Optimizing Use of On-Demand Therapy

Experience With Apomorphine On-Demand Therapy in PD

Practical Advice on the Management of PD OFF Episodes